Showing 1 - 13 results of 13 for search 'K. SUBRAMANIAN', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
The effects of regenerative injection therapy compared to corticosteroids for the treatment of lateral Epicondylitis: a systematic review and meta-analysis by Julie Barnett, Madison N. Bernacki, Jessica L. Kainer, Hannah N. Smith, Annette M. Zaharoff, Sandeep K. Subramanian
Published 2019-11-01
Article -
8
Correction to: The effects of regenerative injection therapy compared to corticosteroids for the treatment of lateral Epicondylitis: a systematic review and meta-analysis by Julie Barnett, Madison N. Bernacki, Jessica L. Kainer, Hannah N. Smith, Annette M. Zaharoff, Sandeep K. Subramanian
Published 2020-01-01
Article -
9
PP 4.5 – 00064 Differentiation Enhances Reactivation of Latent HIV-1 Reservoir in CD4+ T Cells in PLWH With > 4 Years of Viral Suppression by Y. Kuzmichev, K. Subramanian, S. Bakkour, C. Lackman-Smith, M. Stone, C. Mallarino-Haeger, R. Ptak, M. Busch, E. Wonderlich, D. Kulpa
Published 2022-12-01
Article -
10
Reference-Guided De Novo Genome Assembly to Dissect a QTL Region for Submergence Tolerance Derived from Ciherang-Sub1 by Yuya Liang, Shichen Wang, Chersty L. Harper, Nithya K. Subramanian, Rodante E. Tabien, Charles D. Johnson, Julia Bailey-Serres, Endang M. Septiningsih
Published 2021-12-01
Article -
11
1074 PK/RO modeling of WTX-124, a tumor-activated IL-2 prodrug, highlights the potential for a substantially improved therapeutic index compared to other IL-2 molecules by Christopher J Nirschl, Kyriakos Economides, Kristin Morris, Andres Salmeron, Daniel J Hicklin, Cynthia Seidel-Dugan, Kulandayan K Subramanian, Randi Isaacs, Sameer Chopra, Celesztina Domonkos
Published 2023-11-01Article -
12
A rapid, multiplex digital PCR assay to detect gene variants and fusions in non‐small cell lung cancer by Bryan Leatham, Katie McNall, Hari K. K. Subramanian, Lucien Jacky, John Alvarado, Dominic Yurk, Mimi Wang, Donald C. Green, Gregory J. Tsongalis, Aditya Rajagopal, Jerrod J. Schwartz
Published 2023-11-01
Article -
13
737 A phase 1/1b study of the tumor-activated IL-2 prodrug WTX-124 alone or in combination with pembrolizumab in patients with immunotherapy-sensitive locally advanced or metastati... by Brendan Curti, Igor Puzanov, Mateusz Opyrchal, Christopher J Nirschl, Mehmet A Bilen, Kristin Morris, Justin C Moser, Ildefonso Rodriguez Rivera, Saero Park, Marissa Bruno, Paul Windt, Kulandayan K Subramanian, Sameer S Chopra, Randi Isaacs
Published 2023-11-01Article